| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $496K | +462.4% |
| R&D Expense | $18.5M | -13.2% |
| SG&A Expense | $13.8M | +30.5% |
| Operating Income | -$31.8M | -0.0% |
| Net Income | -$31.8M | -2.4% |
| EPS (Basic) | -$1.06 | +15.2% |
| EPS (Diluted) | -$1.06 | +15.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.6M | -50.8% |
| Current Assets | $19.0M | -51.0% |
| Total Assets | $24.1M | -40.7% |
| Current Liabilities | $1.1M | -42.3% |
| Total Liabilities | $1.2M | -36.7% |
| Stockholders' Equity | $22.9M | -40.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.3M | +7.5% |
| Capital Expenditures | $1.6M | +78.6% |
| Investing Cash Flow | -$1.6M | -78.6% |
| Financing Cash Flow | $11.8M | -59.3% |
| Free Cash Flow | -$28.9M | +5.0% |